Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linzagolix long-term extension for endometriosis-associated pain
NCT04372121Phase 3Terminated
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Mar 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of linzagolix in endometriosis, sponsored by Kissei Pharmaceutical Co., Ltd.. Started Mar 2020; status: terminated.
02
Drugs
linzagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT04372121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04372121.